Cover Image

Neutrophil Gelatinase-Associated Lipocaline (NGAL) an early predictive biomarker than Urea in contrast induced Nephropathy

Shobha M.*, Shanthi Naidu, Vijayaraghavan R., Mujahid M., Senthil Kumar S.


Coronary angiography and percutaneous coronary interventions depend on iodinated and non- iodinated contrast media and consequently pose the risk of contrast induced acute kidney injury (AKI). This is an important complication that accounts for significant number of cases of hospital acquired renal failure, with adverse effects on prognosis and health care. Aim of this study is to evaluate Neutrophil Gelatinase- Associated Lipocalin (NGAL) as an early biomarker in AKI than that of urea. 30 animals were randomly divided into 10 different cages having 3 animals in each cage. Further cages were randomly divided into 5 groups (6 animals in a group). Dose of 0.5ml of iohexol was intraperitonealy injected into animals. Blood samples were collected by bleeding retroorbital plexus before and after inducing contrast and centrifuged serum was stored at -200c for further analysis. Increased levels of NGAL was indicated in group 2 (6 hours) and remained elevated in group 3 (12 hours) when compared to that of baseline levels before contrast. The levels of urea were increased in group 1 (3 hours) and group 3 (12 hours) after contrast when compared to level of baseline before contrast. Elevated levels of NGAL among the groups was statistically significant p<0.05. The increased level of urea at the end of 3 hours is probably due to dehydration after contrast induction. Estimation of serum NGAL after contrast induced radiological procedures especially after coronary angiogram may help to detect early kidney injury, so that preventive measures can be adopted to decrease the damage caused by the contrast induction.


Acute Kidney Injury (AKI); Blood Urea Nitrogen (BUN); Contrast Induced Nephropathy (CIN); Chronic Kidney Disease (CKD) Neutrophil Gelatinase Associated Lipocaline (NGAL); Proximal Convoluted Tubules (PCT); iohexol; Urea.

Full Text:



Kent DM, Jafar TH, Hayward RA, Tighiout H, Lauda M, deJong P, de Zeeuw D etal; Progression risk, urinary proteins excretion and treatment effects of angiotensin converting enzymes inhibition in non-diabetic kidney disease. JAM Soc Nephros. 18 (2007): 1959-1965.

Humisicker LG, Adlers, Caggiula A, England BK, et al., Predictor’s of the progression of renal disease in the Modification of Diet in Renal Disease study. Kidney Int. 51 (1997): 1908-1919.

Eddy AA, Neilson E G. Chronic Kidney disease. Progression: JAM Soc Nephrol. 17:2964- 2966, 2006.

Bolignano D, Coppolino G, Lacquaniti A, Nicocia. G, Buemi M pathological and prognostic value of Neurophil Gelatinase- associated lipocaline (NGAL) in Macroprotein-uric patients with worsening renal function. Kidney Blood Press Res. 31 (2008): 274-279.

Parmar A, Langenberg C, Wan L Bellouro R, Bagshaw SM: epidemiology of septic acute injury. Curr Drug Targets. 10.12 (2009): 1169-1178.

Urbschat A, Obermullar N, Haferkamp A: Biomarkers of kidney injury: Biomarkers. 16.1 (2011):22-30.

Martensson J, Bell M, Oldner A, Xu S Venge P, Martling R: Neutrophil gelatinase-associated lipocalin in adult septic patents with or without kidney injury. Intensive Care Med. 36.8 (2010): 1333:1340.

Bolignano D, Lacquaniti A, Coppolino G, , Compo S, Arena A, Buemi M: Neurophil Gelatinase- associated lipocaline (NGAL) reflects the severity of renal impairment in subjects affected by chronic kidney disease. Kidney Blood Press Res. 31.4 (2008): 255-258.

Comtois R, Bertrand S et al., Low serum urea level in dehydrated patients with central diabetes inspidus. CMAJ. 139.10) (1988): 1965-1969.

United States Renal Data System: Annual Report of the US renal data system 2007. National institute of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD. (2007).

Coresh J Selvin E, Stevens LA, Manzi JW, Eggers P, Van Lente F, Levey AS: Prevalence of chronic kidney disease in the United Sates. JAMA. 298 (2007): 2038-2047.

Mori K, Nakao K: Neutrophil gelatinase-associated lipocaline as the real-time indicator of active kidney damage. Kidney Int. 71 (2007): 967-970.

Morgan DB, Carver ME, Payne RB. "Plasma creatinine and urea: creatinine ratio in patients with raised plasma urea". Br Med J. 2 .6092 (1977): 929–32.



  • There are currently no refbacks.

Copyright (c) 2016 International Journal of Bioassays

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

International Journal of Bioassays is a member of the Publishers International Linking Association, Inc. (PILA), CROSSREF and CROSSMARK (USA). Digital Object Identifier (DOI) will be assigned to all its published content.